In short, the PI3K/AKT pathway is regulated by various RTKs and is identified as one of the prime pathways regulating various stages of NAFLD, starting from lipid accumulation to inflammation and fibrosis. This evidence concerns the gene AKT1 and metabolic dysfunction-associated steatotic liver disease.